Cowen Reiterates Market Perform Rating on Moderna (MRNA), 'there is a clear benefit to continued boosting'
Tweet Send to a Friend
Cowen analyst Tyler Van Buren reiterated a Market Perform rating and $165.00 price target on Moderna (NASDAQ: MRNA).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
